Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
12.30
-0.27 (-2.15%)
Feb 21, 2025, 4:00 PM EST - Market closed
CNCR Holdings List
As of Feb 20, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | RXRX | Recursion Pharmaceuticals, Inc. | 5.02% |
2 | PGEN | Precigen, Inc. | 3.15% |
3 | GNLX | Genelux Corporation | 3.04% |
4 | DNA | Ginkgo Bioworks Holdings, Inc. | 2.93% |
5 | CMPX | Compass Therapeutics, Inc. | 2.88% |
6 | SWTX | SpringWorks Therapeutics, Inc. | 2.70% |
7 | VOR | Vor Biopharma Inc. | 2.22% |
8 | REPL | Replimune Group, Inc. | 2.19% |
9 | EXEL | Exelixis, Inc. | 2.04% |
10 | SDGR | Schrödinger, Inc. | 1.93% |
11 | GLUE | Monte Rosa Therapeutics, Inc. | 1.89% |
12 | ZYME | Zymeworks Inc. | 1.79% |
13 | BMY | Bristol-Myers Squibb Company | 1.79% |
14 | BPMC | Blueprint Medicines Corporation | 1.75% |
15 | IBRX | ImmunityBio, Inc. | 1.67% |
16 | IPHA | Innate Pharma S.A. | 1.63% |
17 | ELVN | Enliven Therapeutics, Inc. | 1.53% |
18 | BNTX | BioNTech SE | 1.53% |
19 | MRUS | Merus N.V. | 1.52% |
20 | RVMD | Revolution Medicines, Inc. | 1.52% |
21 | HCM | HUTCHMED (China) Limited | 1.48% |
22 | IMCR | Immunocore Holdings plc | 1.45% |
23 | DAWN | Day One Biopharmaceuticals, Inc. | 1.44% |
24 | SNDX | Syndax Pharmaceuticals, Inc. | 1.41% |
25 | ACLX | Arcellx, Inc. | 1.36% |
26 | GMAB | Genmab A/S | 1.35% |
27 | MGNX | MacroGenics, Inc. | 1.34% |
28 | ALLO | Allogene Therapeutics, Inc. | 1.31% |
29 | KPTI | Karyopharm Therapeutics Inc. | 1.27% |
30 | SMMT | Summit Therapeutics Inc. | 1.25% |
31 | KYMR | Kymera Therapeutics, Inc. | 1.23% |
32 | AURA | Aura Biosciences, Inc. | 1.22% |
33 | LEGN | Legend Biotech Corporation | 1.21% |
34 | XNCR | Xencor, Inc. | 1.19% |
35 | JANX | Janux Therapeutics, Inc. | 1.19% |
36 | MRK | Merck & Co., Inc. | 1.19% |
37 | NUVB | Nuvation Bio Inc. | 1.18% |
38 | NUVL | Nuvalent, Inc. | 1.18% |
39 | INBX | Inhibrx Biosciences, Inc. | 1.17% |
40 | ARVN | Arvinas, Inc. | 1.17% |
41 | ACRV | Acrivon Therapeutics, Inc. | 1.14% |
42 | CRBU | Caribou Biosciences, Inc. | 1.11% |
43 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.07% |
44 | RAPT | RAPT Therapeutics, Inc. | 1.07% |
45 | NRIX | Nurix Therapeutics, Inc. | 1.07% |
46 | ACET | Adicet Bio, Inc. | 1.07% |
47 | RCUS | Arcus Biosciences, Inc. | 1.02% |
48 | TYRA | Tyra Biosciences, Inc. | 1.01% |
49 | ITOS | iTeos Therapeutics, Inc. | 0.99% |
50 | REGN | Regeneron Pharmaceuticals, Inc. | 0.97% |
As of Feb 20, 2025